Moonvalley Hires VFX Trailblazer Ed Ulbrich to Lead Strategic Growth in AI-Powered Entertainment
LOS ANGELES--(BUSINESS WIRE)--Moonvalley, an AI research company building foundational AI video models and tools trained exclusively on licensed content, today announced the appointment of visual effects industry veteran Ed Ulbrich as Head of Strategic Growth & Partnerships.
In this role, Ulbrich will help shape the company's broader growth strategy while deepening Moonvalley's relationships across studios, brands, agencies, and creative communities. He will also collaborate closely with Moonvalley's studio arm, Asteria Film Co., to accelerate adoption and integration of its technology within professional filmmaking communities and workflows.
Ulbrich brings over 30 years of experience driving innovation at the intersection of storytelling, production, and technology. His credits include some of cinema's most ambitious films including Top Gun: Maverick, Black Panther, Avengers: Infinity War, The Curious Case of Benjamin Button, and Titanic. He also produced the sci-fi epic Ender's Game and helped pioneer live digital human performances with the now-iconic 'Tupac Shakur hologram' at Coachella.
Most recently, Ulbrich served as Chief Content Officer and President of Production at Metaphysic, where he worked with major studios, streamers, talent, brands, agencies, and labels to integrate generative AI into high-end production and post. Over three decades, he has led innovation in visual effects across film, TV, streaming, advertising, music videos, and live entertainment. Beyond features, he has delivered VFX for more than 500 commercials for global brands, earning honors including the Cannes Lions Titanium Award. He held senior roles at Deluxe and spent two decades at Academy Award-winning Digital Domain—co-founded by James Cameron, Scott Ross, and Stan Winston—where he also served as CEO.
The announcement reflects Hollywood's evolving relationship with AI technology. Following industry strikes partly centered on AI concerns, studios are seeking partners who can deliver professional tools while respecting creators' rights. Moonvalley's approach of building models exclusively from licensed content directly addresses these concerns.
"From his pioneering work on 'Benjamin Button' to leading AI adoption and integration at Metaphysic, Ed knows how to turn innovative technology into tools that actually work for filmmakers at scale,' said Naeem Talukdar, Co-Founder and CEO of Moonvalley. 'He knows what it takes to earn the trust of filmmakers and how to bring transformative technology into their workflows. We're thrilled to have someone with his expertise and relationships help us bring this technology to the studios and creators who will define its future.'
Ulbrich's appointment follows Moonvalley's launch of Marey, the first high-quality AI video model trained exclusively on licensed content. Named after pioneering cinematographer Etienne-Jules Marey, the model proves that powerful generative AI can be built without exploiting creators' work - something tech giants have claimed is impossible.
'I've spent my career pushing the boundaries of how technology serves storytelling,' said Ulbrich. 'What drew me to Moonvalley is their respect for the craft, their use of clean, licensed data, and their focus on empowering creators without compromise. They're solving the right problems the right way, and that's exactly what the industry needs right now. This is the kind of company that can actually change how films get made, and I'm all in.'
Hollywood is at a critical crossroads with generative AI. The technology could slash production costs and democratize high-quality content creation, but adoption has been slow over legal concerns about training data and tools that fall short of professional standards. Moonvalley's clean-data approach and focus on filmmaker needs position it to break through these barriers.
About Moonvalley
Moonvalley is an AI research company building next-generation models and tools for creative professionals. The company brings together talent from DeepMind, Google, Meta, Microsoft, TikTok, and leading entertainment companies, unified around advancing visual intelligence. Through partnerships with film studios, production companies, and brands, Moonvalley is proving that powerful generative AI can be built while respecting artists' and creators' rights.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
4 hours ago
- Business Wire
GE HealthCare drives innovation in theranostics with latest technological advances
CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare's MIM Software introduces LesionID Pro with automated zero-click pre-processing i – an AI-powered innovation to help aid physician decision making and therapy response monitoring. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief Share With cancer accounting for over 10 million deaths globally each year, ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combining advanced diagnostic imaging and radiopharmaceuticals with targeted therapies, theranostics enables a personalized, patient-centric approach that may help improve disease detection, treatment accuracy, and overall quality of life. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief of Nuclear Medicine, Associate Clinical Professor, Department of Radiological Sciences, University of California, Irvine. 'With tools like GE HealthCare's Omni Legend, StarGuide, and MIM software at our disposal, we now have the ability to visualize disease with great clarity, quantify tumor burden efficiently, and make fast, informed decisions. These advancements are not only helping enhance diagnostic accuracy and therapy monitoring but are also opening the door to dosimetry—ultimately helping improve outcomes for our patients. This is precision care in action, and it's making a real difference in patients' lives.' Central to the practice of theranostics is molecular imaging, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), which provides detailed, patient-specific insights to guide and monitor treatment. However, accessing these insights – like whole-body tumor burden, which represents the total amount of cancer is in the body – has traditionally required time-consuming manual analysis, resulting in clinical and operational challenges. In response, GE HealthCare's MIM Software is introducing LesionID Pro with automated zero-click pre-processing, i designed with AI-powered automation to help physicians access reliable whole-body tumor burden statistics without having to spend hours manually segmenting lesions, removing normal physiologic uptake, and registering multiple patient images for comparison. In addition to turning manual pre-processing into a zero-click experience, this new version of LesionID Pro comes with significant algorithm improvements that provide physicians with a precise whole-body tumor volume to review and finalize. Intuitive, user-friendly tools were intentionally designed with input from leading theranostics practitioners with the ultimate goal of making whole-body tumor burden analysis a practical clinical reality and help shorten physicians' time-to-report. 'At GE HealthCare, we are dedicated to providing clinicians the precision care tools needed for the adoption and practice of theranostics,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We designed our portfolio of precision care solutions to evolve with healthcare system needs and help support a patient's entire care journey – from the imaging equipment needed for a noninvasive look at a patient's anatomy and treatment monitoring, to novel radiopharmaceuticals used to diagnose and monitor disease and the systems required to produce them, to the software optimized to enable data-driven decision-making. In the hands of clinicians, these tools help advance the global practice of personalized medicine and help improve patient outcomes.' Also on display at #SNMMI25, as part of GE HealthCare's comprehensive portfolio of theranostics-enabling solutions for clinical and operational excellence, are the following innovations: MINItrace Magni, iii GE HealthCare's newest cyclotron technology, designed with a small footprint (about the size of a commercial refrigerator) and the goal of providing an easy-to-site, easy-to-install solution for the reliable, in-house production of commercial PET tracers and radiometals, including Gallium-68, used in diagnostic imaging to support personalized care plans. Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities. Omni Legend is a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands by enabling clinicians to reduce dose by up to 40% iv while maintaining exceptional image quality. Supportive of the diagnostic portion of theranostics, the system continues to gain in popularity, representing the company's fastest-ever-selling PET/CT. v StarGuide is a digital SPECT/CT with a 12 CZT detector design that delivers high-quality 3D images and short scan times. Optimized for certain theranostic procedures, the system is designed to help clinicians pinpoint the size, shape, and position of lesions and monitor therapy with exceptional precision. Its flexibility in patient scanning and workflow efficiencies also support high patient throughput and help reduce complexity. For oncology patients, especially those in pain, short scans can help enhance comfort and overall experience. Aurora is an advanced dual-head SPECT/CT designed with excellent diagnostic capabilities vi and streamline workflows, offering clinicians excellent image quality and operational efficiency. Its CT has a 40 mm detector – twice the detector coverage compared to CTs of other hybrid systems vii – with the ability to reduce the dose up to 82%, viii support accurate quantitation, and help clinicians make the personalized care decisions that are at the heart of theranostics. Theranostics Pathway Manager Tile is an easy-to-use application, available on GE HealthCare's Command Center software, that is designed to simplify the time-consuming task of coordinating the theranostics care pathway. It does so by tracking patient readiness for therapy, eliminating the need for manual data gathering across disparate systems (e.g., labs, scheduling, ordering, spreadsheets), and providing a unified, up-to-date view of each patient's treatment journey. Oregon Health & Science University will be an early adopter. 'Every day counts when it comes to cancer care. The latest theranostics solutions will help our care teams more quickly and easily keep tabs on patient readiness and reduce patient coordination time—freeing up more time for clinicians to focus on direct patient care,' says Erik Mittra, M.D., Ph.D., professor of diagnostic radiology in the at Oregon Health & Science University. Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, imaging, informatics, and molecular imaging agents necessary for the practice and advancement of precision care. For more information on GE HealthCare's innovative portfolio of theranostics-enabling solutions, please visit SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region. ii Cancer. World Health Organization. Published February 3, 2022. Accessed March 2, 2023. iii Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked. iv Omni Legend 21cm as compared to Discovery MI Gen1 20cm. As demonstrated in phantom testing. v Based on orders data of GE HealthCare PET/CT systems since 2010. vi Compared to NM/CT 870 DR. vii As compared to NM/CT 870 DR with Optima 540 CT. viii a ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality (Image quality as defined by low contrast detectability). viii b In clinical practice, the use of ASiR‐V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR‐V and FBP. The LCD was measured using 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using a model observer method.
Tom's Guide
9 hours ago
- Tom's Guide
5 Marvel movies worth watching again before 'Ironheart' comes out next week
For anyone who knows the name Ryan Coogler, "Ironheart" on Disney Plus is a show you're going to want to watch. Debuting next week, it looks like a light-hearted origin story for the character first introduced in "Black Panther: Wakanda Forever," named Riri Williams. But Executive Producer Coogler has been on a roll lately. He not only directed that 2022 film but also the well-received "Sinners," which already has Oscar buzz. Plus, he directed the original "Black Panther" as it can be hard to keep all of these Disney shows straight if you haven't watched the recent Marvel films since they came out a few years ago. To help, here's a homework assignment. These five movies will serve as a refresher for the Black Panther superhero and help prepare you for going back to Wakanda when "Ironheart" comes out June 24. Each movie is also available to watch on Disney Plus making this assignment super easy. (Note: These movies are presented in the order of which ones are worth watching first, starting with the two main "Black Panther" films, but you can watch them in any order.) The film that started it all, "Black Panther" from 2018, starred the late Chadwick Boseman as a superhero gifted with super strength and even more super technology. He wore the Vibranium Panther Suit and had claws that could rip through just about anything. The most interesting character trait with Black Panther, though, was that he was also the King of Wakanda. That means there are elements of a monarchy to the series and a deep family dynamic. It's not quite clear how Riri Williams, as Ironheart, will factor into that equation. Once you are done watching "Black Panther," the next best option is to (re)watch "Black Panther: Wakanda Forever" because it introduces the Ironheart character. We first meet Riri Williams as an MIT genius experimenting with vibranium technology. The film, released in 2022, was partly an origin story for Ironheart — even if the main story arc was more about the character Shuri becoming a new iteration of Black Panther. We also first meet the villain, Namor. Released way back in 2016, but still one of the best Marvel movies to date, "Captain America: Civil War" introduced Black Panther with a compelling backstory. Chadwick Boseman's character T'Challa is introduced in Civil War as the Prince of Wakanda. His father, King T'Chaka, is part of a delegation intending to sign the Sokovia Accords to put restrictions on the Avengers. He is killed when a bomb explodes, setting the stage for T'Challa to become not only King of Wakanda but also the Black Panther to honor his late father. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Marvel knows how to build momentum for their characters — at least, that was true back in 2018. After Black Panther came out in February 2019, the superhero emerged as a key player in "Avengers: Infinity War" that April. (It's hard to remember both films were released only months apart.) Fortunately, that meant it was also easy to remember Black Panther — who ends up leading a massive battle against Thanos and his army. In case any of us need a reminder (and this is a major spoiler alert): Black Panther was part of the blip in "Infinity War." His character is restored in "Avengers: Endgame," but due to the real-life passing of Chadwick Boseman, the Black Panther mantle is passed to his on-screen sister Shuri in "Wakanda Forever. "That's a good backstory to keep in mind. "Ironheart" doesn't focus on Shuri, but we're sure there are flashbacks or references throughout the show. That's because Black Panther is a protector of sorts for Ironheart as Riri Williams learns the ropes.
Business Wire
15 hours ago
- Business Wire
EMEREN GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Emeren Group Ltd.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Emeren Group Ltd. (NYSE: SOL) to Shurya Vitra Ltd. Under the terms of the proposed transaction, shareholders of Emeren Group will receive $0.20 in cash per ordinary share or $2.00 in cash per American Depositary Share. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
